Roderich E. Schwarz

7.4k total citations · 1 hit paper
184 papers, 5.7k citations indexed

About

Roderich E. Schwarz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Roderich E. Schwarz has authored 184 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Oncology, 69 papers in Pulmonary and Respiratory Medicine and 65 papers in Surgery. Recurrent topics in Roderich E. Schwarz's work include Pancreatic and Hepatic Oncology Research (52 papers), Gastric Cancer Management and Outcomes (37 papers) and Gastrointestinal Tumor Research and Treatment (19 papers). Roderich E. Schwarz is often cited by papers focused on Pancreatic and Hepatic Oncology Research (52 papers), Gastric Cancer Management and Outcomes (37 papers) and Gastrointestinal Tumor Research and Treatment (19 papers). Roderich E. Schwarz collaborates with scholars based in United States, China and Germany. Roderich E. Schwarz's co-authors include David Smith, Margaret A. Schwarz, Niranjan Awasthi, Daniel G. Coit, Jeffrey S. Groeger, David S. Klimstra, Sarah L. Blair, John C. Hiserodt, David Z. J. Chu and Alan D. Turnbull and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Roderich E. Schwarz

175 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of Total Lymph Node Count on Staging and Survival After Gastrectomy for Gastric Cancer: Data From a Large US-Population Database

2005 460 citations David Smith, Roderich E. Schwarz et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Roderich E. Schwarz

Since Specialization

Citations

This map shows the geographic impact of Roderich E. Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roderich E. Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roderich E. Schwarz more than expected).

Fields of papers citing papers by Roderich E. Schwarz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roderich E. Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roderich E. Schwarz. The network helps show where Roderich E. Schwarz may publish in the future.

Co-authorship network of co-authors of Roderich E. Schwarz

This figure shows the co-authorship network connecting the top 25 collaborators of Roderich E. Schwarz. A scholar is included among the top collaborators of Roderich E. Schwarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roderich E. Schwarz. Roderich E. Schwarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low incisional hernia incidence using a large-bite, low-tension technique for celiotomy closure 2023 ·Surgery Open Science ·(unknown), (unknown), (unknown), (unknown), Roderich E. Schwarz	0
2	Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models 2023 ·Frontiers in Oncology ·Niranjan Awasthi, Margaret A. Schwarz, (unknown), Changhua Zhang, Frank Hilberg, Roderich E. Schwarz	2
3	Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy 2022 ·Molecular Cancer Therapeutics ·Niranjan Awasthi, Margaret A. Schwarz, Changhua Zhang, Stephan G. Klinz, (unknown), (unknown), (unknown), Roderich E. Schwarz	4
4	Augmentation of Nab -Paclitaxel Chemotherapy Response by Mechanistically Diverse Antiangiogenic Agents in Preclinical Gastric Cancer Models 2018 ·Molecular Cancer Therapeutics ·Niranjan Awasthi, Margaret A. Schwarz, Changhua Zhang, Roderich E. Schwarz	10
5	Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral operations 2018 ·PMC ·(unknown), Roderich E. Schwarz	0
6	Pancreatic ductal adenocarcinoma cell secreted extracellular vesicles containing ceramide-1-phosphate promote pancreatic cancer stem cell motility 2018 ·Biochemical Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), Niranjan Awasthi, Roderich E. Schwarz, Robert V. Stahelin, Margaret A. Schwarz	23
7	Quality measurement affecting surgical practice: Utility versus utopia 2017 ·The American Journal of Surgery ·Leonard R. Henry, Urs von Holzen, (unknown), (unknown), (unknown), (unknown), Roderich E. Schwarz	7
8	Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity 2016 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), Charitharth Vivek Lal, (unknown), (unknown), Anna Schwarz, Niranjan Awasthi, Roderich E. Schwarz, Margaret A. Schwarz	20
9	Enhancement of Nab-Paclitaxel Antitumor Activity through Addition of Multitargeting Antiangiogenic Agents in Experimental Pancreatic Cancer 2014 ·Molecular Cancer Therapeutics ·Niranjan Awasthi, Changhua Zhang, Anna Schwarz, Stefan Hinz, Margaret A. Schwarz, Roderich E. Schwarz	18
10	PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer 2013 ·Molecular Cancer Therapeutics ·Katherine T. Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, Stefan Hinz, Keith Dredge, Roderich E. Schwarz, Rolf A. Brekken	62
11	The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer 2013 ·International Journal of Oncology ·(unknown), Niranjan Awasthi, Margaret A. Schwarz, Roderich E. Schwarz	30
12	BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer 2012 ·Molecular Cancer Therapeutics ·Niranjan Awasthi, Changhua Zhang, (unknown), Margaret A. Schwarz, Roderich E. Schwarz	66
13	Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement 2012 ·HPB ·Roderich E. Schwarz, Jordan Berlin, Heinz Josef Lenz, Bernard Nordlinger, Laura Rubbia‐Brandt, Michael A. Choti	40
14	Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases 2010 ·Annals of Surgical Oncology ·William G. Rule, Robert Timmerman, Liyue Tong, Ramzi Abdulrahman, Jeffrey Meyer, Thomas Boike, Roderich E. Schwarz, Paul T. Weatherall, (unknown)	150
15	EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer 2009 ·Annals of Surgical Oncology ·Roderich E. Schwarz, Niranjan Awasthi, (unknown), Danielle E. Cafasso, Margaret A. Schwarz	23
16	Paint-Only Is Equivalent to Scrub-and-Paint in Preoperative Preparation of Abdominal Surgery Sites 2005 ·Journal of the American College of Surgeons ·Joshua D.I. Ellenhorn, David Smith, Roderich E. Schwarz, Mark H. Kawachi, Timothy G. Wilson, Kathryn F. McGonigle, Lawrence D. Wagman, I. Benjamin Paz	45
17	Case Report: Gastric Adenomyoma: Definitely Benign or Defiantly Premalignant? 2004 ·Digestive Diseases and Sciences ·Daphne P. Ly, Nicola Barnard, Roderich E. Schwarz	10
18	Factors predicting hospitalization after operative treatment for gastric carcinoma in patients older than 70 years. 1997 ·PubMed ·Roderich E. Schwarz, Martin S. Karpeh, Murray F. Brennan	33
19	Inferior vena cava filters in cancer patients: indications and outcome. 1996 ·Journal of Clinical Oncology ·Roderich E. Schwarz, (unknown), Kevin C. Conlon, Michael Burt	68
20	Effects of splenectomy on the development of tumor-specific immunity 1990 ·Journal of Surgical Research ·Roderich E. Schwarz, John C. Hiserodt	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact